These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35398032)

  • 21. Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma.
    Wang P; Mo R; Lai R; Xu Y; Lu J; Zhao G; Liu Y; Cao Z; Wang X; Li Z; Lin L; Zhou H; Cai W; Wang H; Bao S; Xiang X; Xie Q
    Oncotarget; 2017 Dec; 8(62):105407-105424. PubMed ID: 29285260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of
    Shi H; He H; Ojha SC; Sun C; Fu J; Yan M; Deng C; Sheng Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160486
    [No Abstract]   [Full Text] [Related]  

  • 23. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.
    Takeuchi JS; Fukano K; Iwamoto M; Tsukuda S; Suzuki R; Aizaki H; Muramatsu M; Wakita T; Sureau C; Watashi K
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Treeprasertsuk S; Tanwandee T; Charatcharoenwitthaya P; Thongsawat S; Leerapun A; Piratvisuth T; Boonsirichan R; Bunchorntavakul C; Pattanasirigool C; Pornthisarn B; Tuntipanichteerakul S; Sripariwuth E; Jeamsripong W; Sanpajit T; Poovorawan Y; Komolmit P
    Antivir Ther; 2018; 23(1):67-75. PubMed ID: 28635613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
    Xiao Q; Fu B; Chen P; Liu ZZ; Wang W; Ye Q
    Medicine (Baltimore); 2016 Dec; 95(50):e5609. PubMed ID: 27977601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
    Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
    Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
    Lin YY; Yu MW; Lin SM; Lee SD; Chen CL; Chen DS; Chen PJ
    Cancer; 2017 Oct; 123(20):3966-3976. PubMed ID: 28662289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.
    Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F
    Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel evidence indicates the presence and replication of hepatitis B virus in breast cancer tissue.
    Qin B; Zhao K; Wei J; Wang X; Xu M; Lang J; Sun H; Jin K
    Oncol Rep; 2020 Jan; 43(1):296-305. PubMed ID: 31746395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive assessment showed no associations of variants at the SLC10A1 locus with susceptibility to persistent HBV infection among Southern Chinese.
    Zhang Y; Li Y; Wu M; Cao P; Liu X; Ren Q; Zhai Y; Xie B; Hu Y; Hu Z; Bei J; Ping J; Liu X; Yu Y; Guo B; Lu H; Liu G; Zhang H; Cui Y; Mo Z; Shen H; Zeng YX; He F; Zhang H; Zhou G
    Sci Rep; 2017 Apr; 7():46490. PubMed ID: 28429786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status.
    Ezzikouri S; Chihab H; Elhabazi A; Wakrim L; Benjelloun S
    BMC Infect Dis; 2017 Jan; 17(1):99. PubMed ID: 28125961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP.
    Huang H; Huang HC; Chiou WC; Lin LC; Chen JC; Liu HK; Lai YH; Huang C
    Antiviral Res; 2021 Nov; 195():105184. PubMed ID: 34627935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration of Na
    Oswald A; Chakraborty A; Ni Y; Wettengel JM; Urban S; Protzer U
    Sci Rep; 2021 Oct; 11(1):19799. PubMed ID: 34611272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
    Luo X; Wang Y; Shen A; Deng H; Ye M
    BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTCP and beyond: opening the door to unveil hepatitis B virus entry.
    Watashi K; Urban S; Li W; Wakita T
    Int J Mol Sci; 2014 Feb; 15(2):2892-905. PubMed ID: 24557582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host genetic background affects the course of infection and treatment response in patients with chronic hepatitis B.
    Rybicka M; Woziwodzka A; Romanowski T; Sznarkowska A; Stalke P; Dręczewski M; Bielawski KP
    J Clin Virol; 2019 Nov; 120():1-5. PubMed ID: 31505315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 6 inhibits HBV entry through NTCP down regulation.
    Bouezzedine F; Fardel O; Gripon P
    Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.